Nipro Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NPRRF research report →
Price Chart
About the company
Nipro Corporation, along with its affiliated companies, operates across three primary business divisions: medical devices, pharmaceuticals, and pharmaceutical packaging. The company's Medical Device sector is dedicated to the development, production, and distribution of an extensive selection of disposable medical products. These offerings encompass specialized items for renal treatment, interventional procedures and anesthesia, injection and infusion therapies, dialysis, cardiopulmonary support, diabetes management, and cell culture applications.
- CEO
- Yoshihiko Sano
- IPO
- 2018
- Employees
- 36,259
- HQ
- Osaka, JP
Get TickerSpark's AI analysis on NPRRF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
- Market Cap
- $1.60B
- P/E
- 21.80
- PEG
- -25.10
- P/S
- 0.38
- P/B
- 0.71
- EV/EBITDA
- 7.83
- Div Yield
- 2.15%
- Gross Margin
- 31.55%
- Op Margin
- 5.39%
- Net Margin
- 1.59%
- ROE
- 3.85%
- ROIC
- 2.03%
- 52W High
- $9.96
- 52W Low
- $8.23
- 50D MA
- $9.12
- 200D MA
- $9.62
- Beta
- -0.61
- RSI (14)
- 0
- Avg Volume
- 36
No earnings-call transcripts are available for NPRRF yet.
- Free Float
- 97.8%
- Shares Outstanding
- 163.10M
- Float Shares
- 159.53M
Our NPRRF coverage
Recent articles, reports, and earnings notes.
No research on NPRRF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate NPRRF report →